A detailed history of Caas Capital Management LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Caas Capital Management LP holds 100 shares of BSX stock, worth $9,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 4,200 97.62%
Holding current value
$9,043
Previous $323,000 97.52%
% of portfolio
0.0%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $371,070 - $412,920
-9,000 Reduced 57.09%
6,764 $293,000
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $1.03 Million - $1.18 Million
-26,736 Reduced 62.91%
15,764 $674,000
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $800,629 - $900,509
22,700 Added 114.65%
42,500 $1.64 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $656,370 - $831,006
19,800 New
19,800 $712,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.